PER
Click for more information
0.00% 8.0¢ percheron therapeutics limited

target, page-6

  1. faimac
    9 Posts.
    clock Created with Sketch.
    28/02/08
    10:01
    Post #: 3405539
    Elan, Biogen slide on Tysabri warning
    By Val Brickates Kennedy, MarketWatch
    Last update: 2:46 p.m. EST Feb. 27, 2008
    BOSTON (MarketWatch) - Shares of partners Elan Corp. and Biogen Idec were trending downward Wednesday afternoon, following news that the Food and Drug Administration has issued a new safety warning about its multiple sclerosis drug Tysabri.



    sigh
    ANP Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LU7 Filling the Lithium Conversion Gap: Lithium Universe commits to community collaboration through formation of joint committee for Bécancour
right-arrow Created with Sketch.
NEWS Want to talk crypto? Click here to join the discussion!
right-arrow Created with Sketch.
MBK Metal Bank setting up shop in Saudi Arabia as part of MENA expansion plans
right-arrow Created with Sketch.
NEWS Good habits matters when it comes to finances
right-arrow Created with Sketch.
NEWS Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more
right-arrow Created with Sketch.
SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.9¢ $33.85K 424.8K

Buyers (Bids)

No. Vol. Price($)
3 76080 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 10226 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.